![]() |
||||||||||||||||||||||||||||||||||||||||||
![]() |
||||||||||||||||||||||||||||||||||||||||||
FDA ANNOUNCES RESTRICED ACCESS PROGRAM FOR ZELNORM Rockvile, MD, July 2007. Restricted use of tegaserod maleate (Zelnorm, Ovaries) will be allowed by the FDA. Zelnorm was suspended from the US market in March when a safety analysis linked its use to an increased risk for stroke. Now, after careful analysis, the FDA has concluded that the product may still benefit certain patients who have no other treatment options. "That was one of the more striking aspects of this study," lead investigator Dr Ramachandran Vasan (Boston University School of Medicine, MA) told heartwire. "It actually doesn't matter if the soft drink is regular or diet. There was an association of increased risk of developing the metabolic syndrome with both types of drinks." The consumption of soft drinks has doubled to tripled between 1977 and 2001. During this same time period, soft-drink sizes have also increased to staggering proportions. With evidence that soft-drink consumption is linked with weight gain and obesity as well as an increased risk of diabetes, the investigators questioned whether soft-drink consumption in adults, in amounts that are seemingly innocuous, like one per day, posed any metabolic hazard. Investigators found in an analysis of 6000 subjects that drinking more than one soft drink daily was associated with a 44% greater risk of developing obesity, high triglycerides, low HDL-cholesterol (the good cholesterol), and a tendency toward diabetes. There was also a trend toward an increased risk of developing high blood pressure, but this association did not reach statistical significance. |
CONSUMPTION OF SMALL AMOUNTS OF DARK CHOCOLATE ASSOCIATED WITH REDUCTION IN BLOOD PRESSURE "Although the magnitude of the BP reduction was small, the effects are clinically noteworthy. On a population basis, it has been estimated that a 3-mm Hg reduction in systolic BP would reduce the risk of stroke mortality by 8 percent, of heart disease mortality by 5 percent, and mortality by 4 percent," the authors write. EXERCISE IN OVERWEIGHT MEN HELPS PREVENT HEART DISEASE 188 overweight men were randomly assigned to diet plus exercise, diet alone, exercise alone, or no intervention. The exercise comprised of 1 hour of walking or running on a treadmill, three times a week, at 60–80% of the participants' peak heart rate. After 1 year, men assigned to exercise (with or without diet) had |
|
||||||||||||||||||||||||||||||||||||||||
significantly larger reductions in number of particles carrying cholesterol in the body. Men who exercised also had larger reductions in the ratio of triglycerides to high-density lipoprotein (HDL) cholesterol, which some scientists take to be an indication of improving resistance to insulin caused by obesity. AVANDIA SHOULD REMAIN ON MARKET, PANEL SAYS Washington, D.C., July 30, 2007. The widely used diabetes drug Avandia should remain on the market according to a 22-1 vote by diabetes experts at a special FDA meeting. However, in an earlier 20-3 vote, the panelists said that available data show the drug does increase heart risks. Panelists said the drug’s label should include a so-called “black-box” warning, the most severe the FDA can require, to flag that risk. Some suggested the label caution against using the drug together with insulin because doing so may elevate heart risks. That joint use is currently FDA-approved. The experts also asked that the drug be studied further. The FDA isn’t required to follow the advice of its advisory committees but usually does. About 1 million Americans with Type 2 diabetes use Avandia to control blood sugar by increasing the body’s sensitivity to insulin. That sort of treatment has longbeen presumed to lessen the heart risks already associated with the disease, which is linked to obesity. News that Avandia might actually increase those risks would represent a “serious limitation” of the drug’s benefit, according to the FDA. The FDA is expected to make its final decision on this matter within 60 days. |
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||
US Leads the world in buying drugs
|
||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||